Patients who have poorly controlled type-2 diabetes and colorectal cancer have worse outcomes than patients whose diabetes is controlled or patients without diabetes.
Poorly controlled type 2 diabetes led to more right-sided tumors, more advanced cancer at diagnosis, diagnosis at a younger age, and poorer five year survival.
Researchers at the Dallas Veterans Medical Center reviewed records of patients with colorectal cancer whose also had type 2 diabetes and matched them to a control group of colorectal cancer patients without diabetes. Poorly controlled type 2 diabetes was defined as a HbA1c level of 7.5 percent or more. Read the rest of this entry »


